ACRIVON THERAPEUTICS INC (ACRV) Stock Balance Sheet
NASDAQ:ACRV - Nasdaq - US0048901096 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 39.15M | 39.82M | 36.02M | 29.50M | 99.60M | |||
| Marketable Securities | 110.48M | 139.66M | 91.44M | 98.20M | N/A | |||
| Other Current Assets | 1.69M | 2.15M | 2.23M | 4.30M | 800.00K | |||
| Total Current Assets | 151.33M | 181.63M | 129.69M | 132.10M | 100.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.98M | 8.03M | 7.91M | 6.90M | 5.80M | |||
| Investments And Advances | 15.20M | 5.09M | 0.00 | 41.90M | N/A | |||
| Other Non-Current Assets | 1.84M | 1.84M | 665.00K | 400.00K | 400.00K | |||
| Total Non-Current Assets | 25.02M | 14.96M | 8.57M | 49.10M | 6.20M | |||
| TOTAL ASSETS | 176.35M | 196.59M | 138.26M | 181.20M | 106.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.86M | 16.46M | 8.26M | 5.50M | 1.90M | |||
| Accounts Payable | 3.69M | 758.00K | 5.05M | 900.00K | 1.00M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 100.00K | 100.00K | |||
| Total Current Liabilities | 13.55M | 17.21M | 13.30M | 6.50M | 2.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.41M | 2.59M | 3.77M | 4.20M | 5.00M | |||
| Total Non-Current Liabilities | 2.41M | 2.59M | 3.77M | 4.30M | 5.00M | |||
| TOTAL LIABILITIES | 15.96M | 19.80M | 17.07M | 10.80M | 7.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -216.66M | -196.98M | -116.42M | -56.00M | -24.90M | |||
| Additional Paid In Capital | 376.73M | 373.28M | 237.68M | 226.60M | 1.10M | |||
| Common Shares | 31.00K | 31.00K | 23.00K | 0.00 | 122.50M | |||
| Other Shareholders' Equity | 283.00K | 447.00K | -83.00K | -100.00K | N/A | |||
| Shares Outstanding | 31.35M | 31.23M | 22.52M | 21.90M | 20.90M | |||
| Tangible Book Value per Share | 5.12 | 5.66 | 5.38 | 7.79 | -1.14 | |||
| Total Shareholders' Equity | 160.39M | 176.79M | 121.19M | 170.50M | 98.70M | |||
| TOTAL LIABILITIES AND EQUITY | 176.35M | 196.59M | 138.26M | 181.20M | 106.60M | |||
| Statistics | ||||||||
| Current Ratio | 11.17 | 10.55 | 9.75 | 20.32 | 34.62 | |||
| Return On Assets (ROA) | -47.49% | -40.98% | -43.68% | -17.20% | -15.23% | |||
| Return On Equity (ROE) | -52.22% | -45.57% | -49.83% | -18.28% | -16.45% | |||
All data in USD , ROIC based on taxRate of 0.21